ArticlePloS one2026
Mechanistic insights into triclosan-induced hepatotoxicity: A network toxicology and molecular docking approach.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTriclosan (TCS) is an artificially synthesized broad-spectrum antimicrobial agent, which is widely used in personal care products. It is a new endocrine disruptor and has potential health hazards to human body.
objectiveBased on network toxicology and molecular docking technology, the compounds that may cause hepatotoxicity in triclosan were predicted and the mechanism was discussed.
methodFrom April to May 2025, the targets of triclosan were identified using databases such as STITCH, CTD, Swiss Target Prediction, and TargetNet. Additionally, gene targets associated with liver toxicity were identified from the GeneCards and OMIM databases. The intersection of triclosan-targets and liver toxicity-related gene targets was used to identify candidate targets. Using the String platform, a protein interaction network was constructed for these candidate targets to identify core functional modules within the network. The candidate targets were analyzed for GO and KEGG enrichment using DAVID, and a triclosan-liver toxicity-target pathway network was constructed using Cytoscape 3.10.1 software. Network topology analysis was conducted to screen for key components and targets. Finally, molecular docking was performed on the core targets using CB-Dock2.
results683 candidate targets for liver toxicity caused by triclosan were identified. The core targets for liver toxicity from triclosan production include TP53, EGFR, AKT1, IL6, JUN, and FN1. Molecular docking analysis shows that the binding free energy of triclosan with these core targets is less than -5.5 kcal/mol. The comprehensive analysis results showed that the liver damage caused by triclosan was mainly related to the activation of Pathways in cancer, Endocrine resistance, AGE-RAGE signaling pathway in diabetic complications, hepatitis B, and lipid and atherosclerosis signaling pathways.
conclusionThe potential targets and molecular mechanisms of triclosan (TCS) induced liver injury were investigated, and 6 key targets and 5 pathways were identified, providing a new paradigm for evaluating the health risks caused by environmental pollutants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.